PDCD1 and COVID-19: Similarly, another retrospective analysis from the German tumor registry found that 13 patients with metastatic melanoma treated with PD-1 inhibitors were diagnosed with COVID-19, mostly asymptomatic or with mild clinical symptoms, with no exacerbation of irAEs [24].